Cargando…

Modulation of Amyloid-β and Tau in Alzheimer’s Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and Donepezil

BACKGROUND: Plasma neuronal-derived extracellular vesicles (NDEV) contain proteins of pathological, diagnostic, and therapeutic relevance. OBJECTIVE: We investigated the associations of six plasma NDEV markers with Alzheimer’s disease (AD) severity, cognition and functioning, and changes in these bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alvarez, X. Anton, Winston, Charisse N., Barlow, James W., Sarsoza, Floyd M., Alvarez, Irene, Aleixandre, Manuel, Linares, Carlos, García-Fantini, Manuel, Kastberger, Birgit, Winter, Stefan, Rissman, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697063/ https://www.ncbi.nlm.nih.gov/pubmed/36155516 http://dx.doi.org/10.3233/JAD-220575

Ejemplares similares

Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer’s Disease
por: Alvarez, X Anton, et al.
Publicado: (2020)

Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases
por: Alvarez, X. Anton, et al.
Publicado: (2016)

Transcriptome analyses reveal tau isoform-driven changes in transposable element and gene expression
por: Grundman, Jennifer, et al.
Publicado: (2021)

Plasma Levels of Neuron- and Astrocyte-Derived Exosomal Amyloid Beta1-42, Amyloid Beta1-40, and Phosphorylated Tau Levels in Schizophrenia Patients and Non-psychiatric Comparison Subjects: Relationships With Cognitive Functioning and Psychopathology
por: Lee, Ellen E., et al.
Publicado: (2021)

Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies
por: Rockenstein, Edward, et al.
Publicado: (2015)

Mutant three-repeat tau expression initiates retinal ganglion cell death through Caspase-2
por: Ngolab, Jennifer, et al.
Publicado: (2021)

Effects of cerebrolysin on nerve growth factor system in the aging rat brain
por: Stepanichev, Mikhail, et al.
Publicado: (2017)

Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke
por: Bajenaru, O, et al.
Publicado: (2010)

Role and Impact of Cerebrolysin for Ischemic Stroke Care
por: Mureșanu, Dafin F., et al.
Publicado: (2022)

Evaluation of blood‐based, extracellular vesicles as biomarkers for aging‐related TDP‐43 pathology
por: Winston, Charisse N., et al.
Publicado: (2022)

Efficacy of Cerebrolysin in the reduction of spasticity during stroke rehabilitation
por: Martinez, RM
Publicado: (2017)

Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis
por: Jarosz, Konrad, et al.
Publicado: (2023)

Hippocampal Reduction of α-Synuclein via RNA Interference Improves Neuropathology in Alzheimer’s Disease Mice
por: Leitão, André D.G., et al.
Publicado: (2023)

Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats
por: Georgy, Gehan S., et al.
Publicado: (2013)

Role of Cerebrolysin(®) in Rehabilitation in Ischemic Stroke: A Case Report
por: Chanubol, Ratanapat, et al.
Publicado: (2021)

Cerebrolysin Use in Patients with Liver Damage—A Translational Study
por: Morega, Shandiz, et al.
Publicado: (2022)

Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice
por: Choi, Hee-Jeong, et al.
Publicado: (2022)

Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
por: Ovejero-Benito, María C., et al.
Publicado: (2022)

Effects of Cerebrolysin on Hippocampal Neuronal Death After Pilocarpine-Induced Seizure
por: Kang, Dong Hyeon, et al.
Publicado: (2020)

Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage
por: Morega, Shandiz, et al.
Publicado: (2021)

Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis
por: Kojder, Klaudyna, et al.
Publicado: (2023)

Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials
por: Guekht, Alla, et al.
Publicado: (2017)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
por: Mattsson‐Carlgren, Niklas, et al.
Publicado: (2021)

Effects of Donepezil on Behavioral Manifestations of Thalamic Infarction: A Single-Case Observation
por: Riveros, Rodrigo, et al.
Publicado: (2011)

Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin
por: Onose, G, et al.
Publicado: (2009)

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure
por: Rockenstein, Edward, et al.
Publicado: (2014)

Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke
por: Amiri-Nikpour, Mohammad Reza, et al.
Publicado: (2014)

Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review
por: Park, Yung Ki, et al.
Publicado: (2018)

Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats
por: Kurkin, Denis V., et al.
Publicado: (2021)

Cerebrolysin induces hair repigmentation associated to MART-1/Melan-A reactivation
por: Villarreal-Reyna, Gustavo, et al.
Publicado: (2022)

Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of the CARS Study
por: Strilciuc, Stefan, et al.
Publicado: (2023)

Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil
por: Tariot, Pierre N., et al.
Publicado: (2022)

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson’s Disease
por: Rockenstein, Edward, et al.
Publicado: (2016)

Effects of donepezil on cognitive functions and the expression level of β-amyloid in peripheral blood of patients with Alzheimer's disease
por: Ma, Yunxia, et al.
Publicado: (2018)

Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2018)

Cerebrolysin administration reduces oxidative stress-induced apoptosis in limphocytes from healthy individuals
por: Formichi, Patrizia, et al.
Publicado: (2012)

Cerebrolysin improves sciatic nerve dysfunction in a mouse model of diabetic peripheral neuropathy
por: Dong, Han-yu, et al.
Publicado: (2016)

Cerebrolysin as a New Treatment Option for Post-Stroke Spasticity: Patient and Physician Perspectives
por: Chemer, Nataliia, et al.
Publicado: (2019)

The Avant Rehabilitation Program and Cerebrolysin for Treatment of Post-Stroke Dysphagia: A Case Report
por: Hien, Nguyen Minh, et al.
Publicado: (2019)

Correction to: Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review
por: Park, Yung Ki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_blng53oidh5ble2jds1b135qgk